Fox Christine, EVP of Teva Pharmaceutical Industries TEVA, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $2.7M. The latest trade was on 04/30.

FC

FC

Fox Christine

EVP, U.S. Commercial

Company

Teva Pharmaceutical Industries TEVA

First filing

23/11/22

Trades

22 trades

Buys / sales

0 / 8

12-month net buying

−$2.7M

Last trade

04/30

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Teva Pharmaceutical IndustriesTEVA	Open-market sale	04/30	05/04	21,258 sh	$35.31	$750,619.98	−25.0%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	03/05	03/09	7,924 sh	$31.67	$250,953.08	−8.5%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	03/04	03/06	9,098 sh	$32.46	$295,321.08	−10.8%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	25/11/20	25/11/24	28,229 sh	$24.78	$699,514.62	−30.7%
Teva Pharmaceutical IndustriesTEVA	Open-market sale	25/11/14	25/11/18	30,000 sh	$25.11	$753,300	−51.4%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	25/03/04–25/03/05	25/03/06	6,181 sh2 trades	$15.79avg.	$97,613.59	−9.6%
Teva Pharmaceutical IndustriesTEVA	Open-market sale10b5-1 plan	24/11/20	24/11/21	19,388 sh	$16.87	$327,075.56	−30.5%